115195
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.6 Breast Cancer (Dove Med Press)
- 4.3 Clin Epidemiol
- 2.6 Cancer Manag Res
- 3.2 Infect Drug Resist
- 4.1 Clin Interv Aging
- 6.1 Drug Des Dev Ther
- 4.1 Int J Chronic Obstr
- 8.7 Int J Nanomed
- 2.5 Int J Women's Health
- 3.2 Neuropsych Dis Treat
- 2.4 OncoTargets Ther
- 2.6 Patient Prefer Adher
- 2.6 Ther Clin Risk Manag
- 3.1 J Pain Res
- 3.5 Diabet Metab Synd Ob
- 4.5 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 2.4 Pharmgenomics Pers Med
- 2.6 Risk Manag Healthc Policy
- 4.6 J Inflamm Res
- 2.3 Int J Gen Med
- 3.9 J Hepatocell Carcinoma
- 3.3 J Asthma Allergy
- 2.5 Clin Cosmet Investig Dermatol
- 3.0 J Multidiscip Healthc
已发表论文
基于血清脂质的晚期肝内胆管癌化学免疫治疗预后模型
Authors Jiang C, Long K , Fang T, Li W, Yang L, Chai P, Tao J , Long K
Received 13 October 2025
Accepted for publication 30 December 2025
Published 13 January 2026 Volume 2026:13 569963
DOI https://doi.org/10.2147/JHC.S569963
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Ali Hosni
Chengzhi Jiang,1,2,* Kaijun Long,1,* Tianyuan Fang,2 Wen Li,2 Liu Yang,2 Pengcheng Chai,2 Ji Tao,2 Kaiguo Long1
1Department of Breast and Thyroid Surgery, The Second Affiliated Hospital of Zunyi Medical University, Zunyi City, Guizhou Province, People’s Republic of China; 2Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang Province, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Kaiguo Long, Email LKG5643@163.com Ji Tao, Email taoji66@163.com
Background: Serum lipid levels have been associated with the prognosis of various malignancies.
Aim: To develop a novel nomogram based on serum lipid parameters to predict overall survival in patients with intrahepatic cholangiocarcinoma.
Methods: Serum lipid profiles and survival data were collected prior to the initiation of chemotherapy combined with immunotherapy. Survival analysis was performed to identify prognostic factors associated with ICC. Independent prognostic factors were used to construct a nomogram. The predictive performance of the nomogram was evaluated. External validation of the survival analysis and nomogram for serum lipids was conducted using a validation cohort.
Results: Low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and apolipoprotein A1 were selected for further analysis. Survival analysis demonstrated that patients with low LDL-C, high HDL-C, and high ApoA1 levels exhibited significantly longer OS and PFS. A nomogram incorporating LDL-C and HDL-C was constructed to predict 1-, 2-, and 3-year survival probabilities. The nomogram exhibited favorable predictive performance.
Discussion: Pre-treatment serum levels of LDL-C, HDL-C, and ApoA1 exhibited significant prognostic value for advanced ICC. The nomogram constructed based on LDL-C and HDL-C effectively predicted survival outcomes, providing a theoretical basis to support treatment decision-making and individualized prognostic assessment in clinical practice.
Keywords: Serum lipid levels, Intrahepatic Cholangiocarcinoma, Immunotherapy, Nomogram
1Department of Breast and Thyroid Surgery, The Second Affiliated Hospital of Zunyi Medical University, Zunyi City, Guizhou Province, People’s Republic of China; 2Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang Province, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Kaiguo Long, Email LKG5643@163.com Ji Tao, Email taoji66@163.com
Background: Serum lipid levels have been associated with the prognosis of various malignancies.
Aim: To develop a novel nomogram based on serum lipid parameters to predict overall survival in patients with intrahepatic cholangiocarcinoma.
Methods: Serum lipid profiles and survival data were collected prior to the initiation of chemotherapy combined with immunotherapy. Survival analysis was performed to identify prognostic factors associated with ICC. Independent prognostic factors were used to construct a nomogram. The predictive performance of the nomogram was evaluated. External validation of the survival analysis and nomogram for serum lipids was conducted using a validation cohort.
Results: Low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and apolipoprotein A1 were selected for further analysis. Survival analysis demonstrated that patients with low LDL-C, high HDL-C, and high ApoA1 levels exhibited significantly longer OS and PFS. A nomogram incorporating LDL-C and HDL-C was constructed to predict 1-, 2-, and 3-year survival probabilities. The nomogram exhibited favorable predictive performance.
Discussion: Pre-treatment serum levels of LDL-C, HDL-C, and ApoA1 exhibited significant prognostic value for advanced ICC. The nomogram constructed based on LDL-C and HDL-C effectively predicted survival outcomes, providing a theoretical basis to support treatment decision-making and individualized prognostic assessment in clinical practice.
Keywords: Serum lipid levels, Intrahepatic Cholangiocarcinoma, Immunotherapy, Nomogram